Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 87

Similar articles for PubMed (Select 23240026)

1.

Pregnenolone rescues schizophrenia-like behavior in dopamine transporter knockout mice.

Wong P, Chang CC, Marx CE, Caron MG, Wetsel WC, Zhang X.

PLoS One. 2012;7(12):e51455. doi: 10.1371/journal.pone.0051455. Epub 2012 Dec 11.

2.

Pregnenolone sulfate normalizes schizophrenia-like behaviors in dopamine transporter knockout mice through the AKT/GSK3β pathway.

Wong P, Sze Y, Chang CC, Lee J, Zhang X.

Transl Psychiatry. 2015 Mar 17;5:e528. doi: 10.1038/tp.2015.21.

3.

Serotonergic involvement in the amelioration of behavioral abnormalities in dopamine transporter knockout mice by nicotine.

Uchiumi O, Kasahara Y, Fukui A, Hall FS, Uhl GR, Sora I.

Neuropharmacology. 2013 Jan;64:348-56. doi: 10.1016/j.neuropharm.2012.07.016. Epub 2012 Jul 15.

4.

Locomotor hyperactivity in 14-3-3ζ KO mice is associated with dopamine transporter dysfunction.

Ramshaw H, Xu X, Jaehne EJ, McCarthy P, Greenberg Z, Saleh E, McClure B, Woodcock J, Kabbara S, Wiszniak S, Wang TY, Parish C, van den Buuse M, Baune BT, Lopez A, Schwarz Q.

Transl Psychiatry. 2013 Dec 3;3:e327. doi: 10.1038/tp.2013.99.

5.

Norepinephrine transporter blockade can normalize the prepulse inhibition deficits found in dopamine transporter knockout mice.

Yamashita M, Fukushima S, Shen HW, Hall FS, Uhl GR, Numachi Y, Kobayashi H, Sora I.

Neuropsychopharmacology. 2006 Oct;31(10):2132-9. Epub 2006 Jan 11.

6.

[Neuronal development of the hyperdopaminergic animal model].

Kasahara Y, Arime Y, Kubo Y, Fukui A, Sora I.

Nihon Shinkei Seishin Yakurigaku Zasshi. 2011 Nov;31(5-6):195-9. Review. Japanese.

PMID:
22256607
7.

Nicotine improves cognitive deficits of dopamine transporter knockout mice without long-term tolerance.

Weiss S, Nosten-Bertrand M, McIntosh JM, Giros B, Martres MP.

Neuropsychopharmacology. 2007 Dec;32(12):2465-78. Epub 2007 Mar 21.

8.

Dopamine transporter-dependent and -independent actions of trace amine beta-phenylethylamine.

Sotnikova TD, Budygin EA, Jones SR, Dykstra LA, Caron MG, Gainetdinov RR.

J Neurochem. 2004 Oct;91(2):362-73.

PMID:
15447669
9.

Dissociations between cognitive and motor effects of psychostimulants and atomoxetine in hyperactive DAT-KO mice.

Del'Guidice T, Lemasson M, Etiévant A, Manta S, Magno LA, Escoffier G, Roman FS, Beaulieu JM.

Psychopharmacology (Berl). 2014 Jan;231(1):109-22. doi: 10.1007/s00213-013-3212-8. Epub 2013 Aug 3.

PMID:
23912772
10.

The selective serotonin-2A receptor antagonist M100907 reverses behavioral deficits in dopamine transporter knockout mice.

Barr AM, Lehmann-Masten V, Paulus M, Gainetdinov RR, Caron MG, Geyer MA.

Neuropsychopharmacology. 2004 Feb;29(2):221-8.

11.
12.

Pregnenolone as a novel therapeutic candidate in schizophrenia: emerging preclinical and clinical evidence.

Marx CE, Bradford DW, Hamer RM, Naylor JC, Allen TB, Lieberman JA, Strauss JL, Kilts JD.

Neuroscience. 2011 Sep 15;191:78-90. doi: 10.1016/j.neuroscience.2011.06.076. Epub 2011 Jul 1. Review.

PMID:
21756978
13.

Valproate attenuates hyperactive and perseverative behaviors in mutant mice with a dysregulated dopamine system.

Ralph-Williams RJ, Paulus MP, Zhuang X, Hen R, Geyer MA.

Biol Psychiatry. 2003 Feb 15;53(4):352-9.

PMID:
12586455
14.

Impaired cliff avoidance reaction in dopamine transporter knockout mice.

Yamashita M, Sakakibara Y, Hall FS, Numachi Y, Yoshida S, Kobayashi H, Uchiumi O, Uhl GR, Kasahara Y, Sora I.

Psychopharmacology (Berl). 2013 Jun;227(4):741-9. doi: 10.1007/s00213-013-3009-9. Epub 2013 Feb 9.

PMID:
23397052
15.

Endocannabinoids activate transient receptor potential vanilloid 1 receptors to reduce hyperdopaminergia-related hyperactivity: therapeutic implications.

Tzavara ET, Li DL, Moutsimilli L, Bisogno T, Di Marzo V, Phebus LA, Nomikos GG, Giros B.

Biol Psychiatry. 2006 Mar 15;59(6):508-15. Epub 2005 Sep 30.

PMID:
16199010
16.

Atypical antipsychotics clozapine and quetiapine attenuate prepulse inhibition deficits in dopamine transporter knockout mice.

Powell SB, Young JW, Ong JC, Caron MG, Geyer MA.

Behav Pharmacol. 2008 Sep;19(5-6):562-5. doi: 10.1097/FBP.0b013e32830dc110.

17.

GABA transporter-1 deficiency confers schizophrenia-like behavioral phenotypes.

Yu Z, Fang Q, Xiao X, Wang YZ, Cai YQ, Cao H, Hu G, Chen Z, Fei J, Gong N, Xu TL.

PLoS One. 2013 Jul 29;8(7):e69883. doi: 10.1371/journal.pone.0069883. Print 2013.

18.

A schizophrenia-related sensorimotor deficit links alpha 3-containing GABAA receptors to a dopamine hyperfunction.

Yee BK, Keist R, von Boehmer L, Studer R, Benke D, Hagenbuch N, Dong Y, Malenka RC, Fritschy JM, Bluethmann H, Feldon J, Möhler H, Rudolph U.

Proc Natl Acad Sci U S A. 2005 Nov 22;102(47):17154-9. Epub 2005 Nov 11.

19.
20.

Reduced tumor growth in a mouse model of schizophrenia, lacking the dopamine transporter.

Asada M, Ebihara S, Numachi Y, Okazaki T, Yamanda S, Ikeda K, Yasuda H, Sora I, Arai H.

Int J Cancer. 2008 Aug 1;123(3):511-8. doi: 10.1002/ijc.23562.

PMID:
18470912
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk